{
    "eid": "2-s2.0-85134014828",
    "title": "Long-term oncological outcomes of hypofractionated versus conventional fractionated whole breast irradiation with simultaneous integrated boost in early-stage breast cancer",
    "cover-date": "2022-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Radiology, Nuclear Medicine and Imaging",
            "@code": "2741",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Breast neoplasms",
        "Radiation dose hypofractionation",
        "Radiation oncology",
        "Radiotherapy",
        "Survival analysis"
    ],
    "authors": [
        "Chawalit Lertbutsayanukul",
        "Manida Pitak",
        "Chonnipa Nantavithya"
    ],
    "citedby-count": 2,
    "ref-count": 38,
    "ref-list": [
        "Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries",
        "Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials",
        "Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials",
        "Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality",
        "Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial",
        "Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation",
        "Long-term results of hypofractionated radiation therapy for breast cancer",
        "The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial",
        "The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial",
        "Is the simultaneously integrated boost (SIB) technique for early breast cancer ready to be adopted for routine adjuvant radiotherapy?: statement of the German and the Austrian Societies of Radiooncology (DEGRO/OGRO)",
        "Simultaneous integrated boost irradiation after breast-conserving surgery: physician-rated toxicity and cosmetic outcome at 30 months\u2019 follow-up",
        "Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients",
        "Early-stage breast cancer treated with 3-week accelerated whole-breast radiation therapy and concomitant boost",
        "Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results",
        "Hypofractionation with simultaneous integrated boost for early breast cancer: results of the German multicenter phase II trial (ARO-2010-01)",
        "Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation: report of feasibility and preliminary toxicity",
        "Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue",
        "Five-year local control in a phase II study of hypofractionated intensity modulated radiation therapy with an incorporated boost for early stage breast cancer",
        "Three-year outcomes of breast intensity-modulated radiation therapy with simultaneous integrated boost",
        "Late effects and cosmetic results of simultaneous integrated boost versus sequential boost after conventional irradiation in breast-conserving therapy; out come of 7 months follow-up",
        "Skin toxicity and cosmesis after hypofractionated whole breast irradiation for early breast cancer",
        "Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments",
        "Concomitant intensity modulated boost during whole breast hypofractionated radiotherapy: a feasibility and toxicity study",
        "Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial",
        "Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients",
        "Comparison of acute and late toxicity of two regimens of 3-and 5-week concomitant boost prone IMRT to standard 6-week breast radiotherapy",
        "Long-term patient-rated cosmetic and satisfactory outcomes of early breast cancer treated with conventional versus hypofractionated breast irradiation with simultaneous integrated boost technique",
        "Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial",
        "The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials",
        "Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial",
        "Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial",
        "Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France",
        "Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial",
        "Accelerated fractionation with a concurrent boost for early stage breast cancer",
        "The IM-PORT trials are launched (September 2006)",
        "Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial",
        "Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: considerations regarding FAST and FAST-Forward"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}